Bluejay Diagnostics (BJDX) Current Leases (2022 - 2026)
Bluejay Diagnostics (BJDX) reported Current Leases of $97032.0 for Q1 2026, down 2.97% on a YoY basis from $100002.0 in Q1 2025, and down 2.97% sequentially from $100000.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Current Leases (2022 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 5 years of Current Leases data on file, last reported at $97032.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 2.97% year-over-year to $97032.0; the trailing twelve-month figure through Mar 2026 stood at $97032.0 (down 2.97% YoY), and the FY2025 full-year result was $100000.0, down 11.71% from the prior year.
- Current Leases eased to $97032.0 in Q1 2026, from $100000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $168716.0 in Q3 2023 to a low of $97032.0 in Q1 2026.
- A 5-year average of $131002.1 and a median of $120946.5 in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases plunged 33.94% in 2024 and dropped 2.97% in 2026, its largest moves.
- Tracing BJDX's Current Leases over 5 years: stood at $168706.0 in 2022, then decreased by 3.39% to $162990.0 in 2023, then plunged by 30.51% to $113260.0 in 2024, then slipped by 11.71% to $100000.0 in 2025, then slipped by 2.97% to $97032.0 in 2026.
- Business Quant data shows BJDX's Current Leases at $97032.0 in Q1 2026, $100000.0 in Q4 2025, and $100002.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 97,032.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97,032.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,002.00 |
| Jun 30, 2025 | 100,002.00 |
| Mar 31, 2025 | 100,002.00 |
| Dec 31, 2024 | 113,260.00 |
| Sep 30, 2024 | 111,453.00 |
| Jun 30, 2024 | 128,633.00 |
| Mar 31, 2024 | 145,811.00 |
| Dec 31, 2023 | 162,990.00 |
| Sep 30, 2023 | 168,716.00 |
| Jun 30, 2023 | 168,713.00 |
| Mar 31, 2023 | 168,709.00 |
| Dec 31, 2022 | 168,706.00 |